Internet Archive Scholar

Prognostic implications of calculated Apo‐lipoprotein B in patients with segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut‐points

Saeed Ghodsi, Mehrnaz Mohebi, Seyed‐Ali Sadre‐Bafghi, Hamidreza Poorhosseini, Mojtaba Salarifar, Mohammad Alidoosti, Ali‐Mohammad Haji‐Zeinali, Alireza Amirzadegan, Hassan Aghajani, Yaser Jenab, Zahra Hosseini
2021 Clinical Cardiology  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.3 MB)
https://web.archive.org/web/20210718031546/https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.23610

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

Debates still surround using lipoproteins including Apo-B in risk assessment, management, and prognosis of patients with coronary artery disease. During an acute ST-segment elevation myocardial infarction, Apo-B might help to achieve incremental prognostic information. We sought to determine the potential prognostic utility of calculated Apo-B in a cohort of patients with STEMI undergoing primary PCI. A retrospective cohort study was conducted enrolling 2,259 patients with a diagnosis of acute
more » ... TEMI who underwent primary PCI. Apo-B was obtained using a valid equation based on initial lipid measurements. High Apo-B was defined as a level of 65 or higher. Primary endpoint of the study was major adverse cardiovascular events (MACE). Mean age of the participants was 59.54 years and 77.9% of them were male. After a Median follow up of 15 (6.2) months, high Apo-B was associated with MACE and the OR (95% CI) was 3.02 (1.07-8.47), p = .036. Odds ratios for prediction of MACE pertaining to LVEF, and smoking were 0.97 (p = .044), and 1.07 (p = .033), respectively. However, High Apo-B was not able to predict suboptimal TIMI flow. Accordingly, the Odds ratio was 0.56 (0.17-1.87), p = 0.349. The power of High LDL-C and Non-HDLC for prediction of MACE were assessed in distinct models. Attained odds ratios were [2.40 (0.90-6.36), p = .077] and [1.80 (0.75-4.35), p = 0.191], respectively. Calculated Apo-B appears to be a simple tool applicable for prediction of cardiovascular events in patients with STEMI superior to both Non-HDLC and LDL-C.
doi:10.1002/clc.23610 pmid:33942349 fatcat:gyuwje2nujdmlfwpmcamifd7tu
DOAJ
Citation

Saeed Ghodsi, Mehrnaz Mohebi, Seyed‐Ali Sadre‐Bafghi, Hamidreza Poorhosseini, Mojtaba Salarifar, Mohammad Alidoosti, Ali‐Mohammad Haji‐Zeinali, Alireza Amirzadegan, Hassan Aghajani, Yaser Jenab, Zahra Hosseini. "Prognostic implications of calculated Apo‐lipoprotein B in patients with segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut‐points." Clinical Cardiology 44.6 (2021)